Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Abuse-Deterrent Formulations MeSH Descriptor Data 2025


MeSH Heading
Abuse-Deterrent Formulations
Tree Number(s)
D26.255.075
D27.505.696.034
D27.505.696.663.850.007
D27.505.954.427.005
E02.319.300.127
E05.916.250.500
Unique ID
D000075162
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000075162
Scope Note
Drug formulations or delivery systems intended to discourage the abuse of CONTROLLED SUBSTANCES. These may include physical barriers to prevent chewing or crushing the drug; chemical barriers that prevent extraction of psychoactive ingredients; agonist-antagonist combinations to reduce euphoria associated with abuse; aversion, where controlled substances are combined with others that will produce an unpleasant effect if the patient manipulates the dosage form or exceeds the recommended dose; delivery systems that are resistant to abuse such as implants; or combinations of these methods.
Entry Term(s)
Abuse-Deterrent Formulation
Registry Numbers
0
See Also
Drug Compounding
Public MeSH Note
2018
History Note
2018
Date Established
2018/01/01
Date of Entry
2017/07/11
Revision Date
2020/05/27
Abuse-Deterrent Formulations Preferred
page delivered in 0.155s